Back

Real-world observational data confirm the efficacy of atrial antitachycardia pacing in terminating slow and regular atrial tachyarrhythmias in patients wearing implantable cardiac electronic devices.

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Supra ventricular tachycardia Supraventricular Tachycardia (non-AF) - Treatment EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)

4 More presentations in this session

Presentation thumbnail
Electrogram voltage and pacing threshold before ablation, measured by mini electrodes embedded in an ablation catheter, predict subsequent transmural lesions at the cavotricuspid isthmus in humans
Doctor C. Lazaro Rivera (Madrid, ES)
Abstract Slides
Presentation thumbnail
Predictors of new-onset atrial fibrillation after catheter-ablation of typical atrial flutter
Doctor M. Marinkovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
An optimized non fluoroscopy-guided approach for paroxysmal supraventricular tachycardia diagnosis and ablation
Doctor L. Rossi (Piacenza, IT)
Abstract Slides
Presentation thumbnail
Are the Use of Imaging Technologies before the Procedure Impactful in Outcome of Pulmonary Vein Cryoablation for Recurrent AF ?
Doctor A. Sagone (Sesto San Giovanni, IT)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Supra ventricular tachycardia

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources